Indication
Diffuse Large B-Cell Lymphoma-Recurrent
1 clinical trial
1 product
1 drug
Clinical trial
Early, Risk Adapted CC-99282 + Rituximab Post CAR T-Cell Therapy for Non-Hodgkin's LymphomaStatus: Recruiting, Estimated PCD: 2025-12-31
Product
GolcadomideDrug
Varlilumab